Preferred Label : iohexol;
MeSH definition : An effective non-ionic, water-soluble contrast agent which is used in myelography,
arthrography, nephroangiography, arteriography, and other radiographic procedures.
Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.;
MeSH synonym : iohexol 350;
MeSH hyponym : omnipaque; nycodenz; compound 545; exypaque;
MeSH CAS label : 1,3-Benzenedicarboxamide, 5-(acetyl(2,3-dihydroxypropyl)amino)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-;
MeSH Related Number : 66108-95-0 (Iohexol);
Registry Number MeSH : 66108-95-0;
Wikipedia link : https://en.wikipedia.org/wiki/Iohexol;
Codes EINECS : 266-164-2;
Is substance : O;
UNII : 4419T9MX03;
InChIKey : NTHXOOBQLCIOLC-UHFFFAOYSA-N;
Origin ID : D007472;
UMLS CUI : C0022005;
ATC code(s)
Allowable qualifiers
Automatic exact mappings (from CISMeF team)
CISMeF manual mappings
Currated CISMeF NLP mapping
Pharmacological action(s)
Record concept(s)
Related MeSH Supplementary Concept(s)
- EmboGel [MeSH Supplementary Concept]
- ioxilan [MeSH Supplementary Concept]
- lumagel [MeSH Supplementary Concept]
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
An effective non-ionic, water-soluble contrast agent which is used in myelography,
arthrography, nephroangiography, arteriography, and other radiographic procedures.
Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
https://www.sfndt.org/sites/www.sfndt.org/files/medias/documents/FICHE%20PRATIQUE_EKFC%20iohexol_d%C3%A9cembre%202024.pdf
https://www.sfndt.org/sites/www.sfndt.org/files/medias/documents/FIGURE%20EKFC.pdf
2024
France
scientific and technical information
iohexol
metabolic clearance rate
consensus
reference standards
---
https://www.has-sante.fr/jcms/p_3546286/fr/omnipaque-iohexol-produit-de-contraste-iode
2024
false
false
false
France
insurance, health, reimbursement
iohexol
breast neoplasms
Tumor Size Measurement
neoplasm staging
evaluation of the transparency committee
contrast media
iohexol
---
https://www.has-sante.fr/jcms/p_3497017/fr/omnipaque-iohexol-produit-de-contraste-iode
2024
false
false
false
France
evaluation of the transparency committee
iodine
omnipaque
contrast media
iohexol
---
https://www.has-sante.fr/jcms/p_3259538/fr/xenetix
2021
false
false
false
France
iobitridol
evaluation of the transparency committee
iobitridol
iohexol
---
https://www.has-sante.fr/jcms/p_3152701/fr/xenetix
2020
false
false
false
France
iobitridol
evaluation of the transparency committee
iobitridol
iohexol
iohexol
---
https://www.has-sante.fr/jcms/p_3189749/fr/ultravist
2020
false
false
false
France
iopromide
contrast media
insurance, health, reimbursement
iopromide
evaluation of the transparency committee
iohexol
---
https://www.has-sante.fr/portail/jcms/c_2901465/fr/xenetix
2019
false
false
false
France
evaluation of the transparency committee
xenetix
iobitridol
iohexol
---
https://www.has-sante.fr/jcms/p_3118410/fr/omnipaque
2019
false
false
false
France
iohexol
diagnostic uses of chemicals
angiocardiography
angiography
cervical myelography
phlebography
tomography, X-ray computed
urography
lumbar myelography
iohexol
evaluation of the transparency committee
---
https://www.has-sante.fr/portail/jcms/c_2854448/fr/ultravist-gamme
2018
false
false
false
false
France
French
evaluation of the transparency committee
insurance, health, reimbursement
iopromide
iohexol
---
https://www.has-sante.fr/portail/jcms/c_2796803/fr/xenetix
2017
false
false
false
France
French
evaluation of the transparency committee
iobitridol
contrast media
xenetix
iobitridol
iohexol
---
http://www.lecrat.eu/?s=Produits+de+contraste+iod%C3%A9s+hydrosolubles+-+Allaitement
2015
false
false
false
France
French
drug information
iohexol
x-ray contrast media, iodinated
tomography, X-ray computed
iohexol
breast feeding
contrast media
---
http://www.has-sante.fr/portail/jcms/c_1621570/fr/omnipaque
http://www.has-sante.fr/portail/jcms/c_1621569/fr/omnipaque-15052013-avis-ct11024
http://www.has-sante.fr/portail/display.jsp?id=c_474455
2013
France
French
evaluation of the transparency committee
iohexol
iohexol
insurance, health, reimbursement
Outcome Assessment, Health Care
contrast media
injections
myelography
tomography, X-ray computed
injections, spinal
phlebography
urography
angiocardiography
angiography
---